Cited by 287Fatty Acid Research and HealthNutritional Studies and DietDiet, Metabolism, and Disease

Plasma phospholipid and dietary fatty acids as predictors of type 2 diabetes: interpreting the role of linoleic acid

Open access
Hodge, Allison M, English, Dallas R, O’Dea, Kerin, Sinclair, Andrew J, Makrides, Maria, Gibson, Robert A, Giles, Graham G·2007·The American Journal of Clinical Nutrition

Abstract

Background Dietary fatty acids may be associated with diabetes but are difficult to measure accurately.Objective We aimed to investigate the associations of fatty acids in plasma and diet with diabetes incidence.Design This was a prospective case-cohort study of 3737 adults aged 36-72 y. Fatty acid intake (/kJ) and plasma phospholipid fatty acids (%) were measured at baseline, and diabetes incidence was assessed by self-report 4 y later. Logistic regression excluding (model 1) and including (model 2) body mass index and waist-hip ratio was used to calculate odds ratios (ORs) for plasma phospholipid and dietary fatty acids.Results In plasma phospholipid, positive associations with diabetes were seen for stearic acid [OR model 1, highest versus lowest quintile: 4.14 (95% CI: 2.65, 6.49), P for trend < 0.0001] and total saturated fatty acids [OR model 1: 3.76 (2.43, 5.81), P for trend < 0.0001], whereas an inverse association was seen for linoleic acid [OR model 1: 0.22 (0.14, 0.36), P for trend < 0.0001]. Dietary linoleic [OR model 1: 1.77 (1.19, 2.64), P for trend = 0.002], palmitic [OR model 1: 1.65 (1.12, 2.43), P for trend = 0.012], and stearic [OR model 1: 1.46 (1.00, 2.14), P for trend = 0.030] acids were positively associated with diabetes incidence before adjustment for body size. Within each quintile of linoleic acid intake, cases had lower baseline plasma phospholipid linoleic acid proportions than did controls.Conclusions Dietary saturated fat intake is inversely associated with diabetes risk. More research is required to determine whether linoleic acid is an appropriate dietary substitute.

Integrity signals

Registry

Crossref · 10.1093/ajcn/86.1.189

Cites

40 of 40 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Combination therapy with any two glucose-lowering agents is effective for lowering glucose levels.

    “While combination therapy with any two agents has been shown to be effective for lowering glucose levels 35 , 36 , 37 , 38 , 39 , 40 , 41 , 42 , 43 , 44 , 45 , 46 , combination therapy with three or more agents (other than SU/glinide or DPP‐4 inhibitor/GLP‐1 receptor agonist combinations) has also been shown to be effective for lowering glucose levels 47 , 48 , 49 , 50 , 51 .”

    From Japanese clinical practice guideline for diabetes 2019 (2020) · cites this paper as [36]

  • Poor working environments or social environments may constitute an important risk factor for type 2 diabetes.

    “Poor working environments 35 , 36 , 37 , 38 , 39 or social environments 40 , 41 may constitute an important risk factor for type 2 diabetes.”

    From Japanese clinical practice guideline for diabetes 2019 (2020) · cites this paper as [36]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Hodge, A. M., English, D. R., O’Dea, K., Sinclair, A. J., Makrides, M., Gibson, R. A., & Giles, G. G.
Affiliations
Deakin University (AU)
Corresponding author
Hodge, Allison M
Venue
The American Journal of Clinical Nutrition
Publisher
Elsevier BV
Published
2007-07
Volume
86
Issue
1
Pages
189-197
ISSN
0002-9165 (ISSN-L)
OpenAlex
W2125895299
Cited by
287
References
40
Citations by year
2026: 9 · 2025: 5 · 2024: 6 · 2023: 8 · 2022: 15 · 2021: 20 · 2020: 18 · 2019: 19 · 2018: 15 · 2017: 16 · 2016: 33 · 2015: 19 · 2014: 17 · 2013: 24 · 2012: 16
FWCI
8.97
Type
journal article
Language
en
Open access
Locations
  • American Journal of Clinical Nutrition (publishedVersion)
  • PubMed (publishedVersion)
  • Deakin Research Online (Deakin University) (submittedVersion)
  • Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion)
Topics
  • Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Nutritional Studies and Diet
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
Keywords
type 2 diabetes, plasma phospholipid fatty acids, dietary fatty acids, linoleic acid, saturated fatty acids, stearic acid, palmitic acid, diabetes risk, body mass index, waist-to-hip ratio, dietary fat intake
MeSH terms
Adult, Aged, Blood Glucose, Diabetes Mellitus, Type 2, Dietary Fats, Female, Humans, Insulin, Male, Middle Aged, Phospholipids, Prospective Studies, Surveys and Questionnaires, Victoria, Cohort Studies, Logistic Models, Case-Control Studies, Linoleic Acid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review